Our research group investigates transcription factor crosstalk in cancers. Especially we focus on deciphering the action of steroid receptors and pioneer factors in prostate cancer.
*** under construction ***
see my website at http://www.uef.fi/en/web/vitamind
Nrf2 is a transcription factor mainly involved in combating cellular stress caused by reactive oxygen and nitrogen species. However, Nrf2 is also involved in cancer and cardiometabolic diseases, making it an essential drug target.
University Lecturer , Biomedicine
01.10.2000 -The scientific interest of our team is on mechanisms of gene regulation and its impact on major common diseases, such as type 2 diabetes, atherosclerosis and cancer. Our investigations use methods of molecular biology, bioinformatics and systems biology.
Professor , Biomedicine
Grant-funded Researcher , Biomedicine